Beacon Therapeutics Raises $170 Million in Series B Funding led by Forbion, Syncona, Oxford Science Enterprises, TCGX, and Advent Life Sciences to Support Ophthalmic Gene Therapy Development
Amount Raised
$170 Million
Round Type
Series B
Investors
Description
Beacon Therapeutics Holdings Limited has raised $170 million in Series B funding led by Forbion, alongside existing investors Syncona and Oxford Science Enterprises, as well as new investors TCGX and Advent Life Sciences. The funds will be used to support the continued clinical development of Beacon's lead asset, AGTC-501 for X-Linked Retinitis Pigmentosa (XLRP) and generate Phase 1/2 clinical trial data for the Company's Dry Age-related Macular Degeneration (dAMD) program.
Quick answer
Beacon Therapeutics raised $170 Million in a Series B round, dated July 3, 2024. Investors: Advent Life Sciences, Tcgx, Oxford Science Enterprises, Syncona and Forbion.
- How much did Beacon Therapeutics raise?
- Beacon Therapeutics raised $170 Million in a Series B round on July 3, 2024.
- Who invested in Beacon Therapeutics?
- Advent Life Sciences, Tcgx, Oxford Science Enterprises, Syncona and Forbion are named as investors in this round.
- What does Beacon Therapeutics do?
- Beacon Therapeutics is a clinical-stage biotechnology company with a mission to save and restore the vision of patients with blinding retinal diseases.
- Where is Beacon Therapeutics based and how big is it?
- Fundz records about 91 employees.
- Who are the decision-makers at Beacon Therapeutics?
- Fundz holds 1 contact at Beacon Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Beacon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- IDRx raised $120M (Series B) on August 7, 2024.
- NeuroTherapia raised $12M (Series B) on August 6, 2024.
- bioAffinity Technologies raised $450K on August 5, 2024.
- bioAffinity Technologies raised $1.3M on August 2, 2024.
- Lapix Therapeutics raised $2.2M on August 2, 2024.
- Healx raised $47M (Series C) on August 1, 2024.
Who to call at Beacon Therapeutics, and when
A new round usually means Beacon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Beacon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beacon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Beacon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beacon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBeacon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.